We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio
Read MoreHide Full Article
Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy. These stocks combine the attractive attributes of both small and large-cap stocks. Top-ranked mid-cap stocks have a high potential of enhancing their profitability, productivity and market share. These may also become large caps in due course of time.
If the economy faces any unforeseen internal or external disturbance, mid-cap stocks will be less susceptible to losses than their large-cap counterparts owing to their less international exposure. On the other hand, if the economy remains stable, these stocks will gain more than small caps due to established management teams, a broad distribution network, brand recognition and ready access to the capital markets.
In the first and second quarters of 2023, like the three major stock indexes, the mid-cap-centric S&P 400 Index ended in positive territory, advancing 3.4% and 4.4%, respectively. Year to date, the S&P 400 has rallied 10.7%. At this stage, it will be prudent to invest in mid-cap stocks to tap the broad-based ongoing rally of 2023.
Our Top Picks
We have narrowed our search to five mid-cap (market capital > $1 billion < $10 billion) stocks with more than 50% returns year to date. These stocks have more upside left for the rest of 2023. These stocks have seen positive earnings estimate revisions in the last 60 days. Each of our picks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Abercrombie & Fitch Co. (ANF - Free Report) has gained from the continued momentum in the Abercrombie brand and improvement in the Hollister brand. Lower freight costs and robust AUR growth aided ANF’s margins. Consequently, ANF expects fiscal 2023 sales growth of 1-3% from the year-ago period’s reported figure of $3.7 billion. ANF’s store optimization and the Always Forward plan bode well.
Abercrombie & Fitch has an expected revenue and earnings growth rate of 3.4% and more than 100%, respectively, for the current year (ending January 2024). The Zacks Consensus Estimate for current-year earnings has improved 45.6% over the last 60 days. The stock price of ANF has surged 62.2% year to date.
InterDigital Inc. (IDCC - Free Report) is focused on strategic acquisitions in order to drive its product portfolio and boost organic growth. IDCC’s extensive portfolio of wireless technology patents provides a significant competitive advantage. IDCC is poised to gain from future growth opportunities fueled by the 5G rollout, while a strong emphasis on research & development helps it to stay at the forefront of wireless technology innovation.
InterDigital has an expected revenue and earnings growth rate of 17.4% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.1% over the last 60 days. The stock price of IDCC has jumped 95.3% year to date.
Shake Shack Inc. (SHAK - Free Report) has been benefiting from various digital initiatives, strong same-shack sales and unit expansion efforts. SHAK’s digital retention continues to be strong. It has also been making more investments in digitization in an effort to sustain its digital guest enhancement strategies in the near term.
Shake Shack has an expected revenue and earnings growth rate of 21.5% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 60 days. The stock price of SHAK has climbed 92.4% year to date.
Amphastar Pharmaceuticals Inc. (AMPH - Free Report) is a specialty pharmaceutical company. AMPH focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. AMPH’s products include Enoxaparin Sodium Injection, Amphadase, Cortrosyn for Injection, and prefilled disposable emergency syringes for crash cart use.
Amphastar Pharmaceuticals has an expected revenue and earnings growth rate of 17.4% and 30%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.8% over the last 60 days. The stock price of AMPH has soared 118% year to date.
PGT Innovations Inc. pioneered the U.S. impact-resistant window and door industry and today is the nation's leading manufacturer and supplier of residential impact-resistant windows and doors. PGTI is also one of the largest window and door manufacturers in the United States.
PGTI’s total line of custom windows and doors is now available throughout the eastern United States, the Gulf Coast and in a growing international market, which includes the Caribbean, South America, and Australia.
PGT Innovations has an expected revenue and earnings growth rate of 0.5% and 8.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.5% over the last seven days. The stock price of PGTI has advanced 57.8% year to date.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio
Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy. These stocks combine the attractive attributes of both small and large-cap stocks. Top-ranked mid-cap stocks have a high potential of enhancing their profitability, productivity and market share. These may also become large caps in due course of time.
If the economy faces any unforeseen internal or external disturbance, mid-cap stocks will be less susceptible to losses than their large-cap counterparts owing to their less international exposure. On the other hand, if the economy remains stable, these stocks will gain more than small caps due to established management teams, a broad distribution network, brand recognition and ready access to the capital markets.
In the first and second quarters of 2023, like the three major stock indexes, the mid-cap-centric S&P 400 Index ended in positive territory, advancing 3.4% and 4.4%, respectively. Year to date, the S&P 400 has rallied 10.7%.
At this stage, it will be prudent to invest in mid-cap stocks to tap the broad-based ongoing rally of 2023.
Our Top Picks
We have narrowed our search to five mid-cap (market capital > $1 billion < $10 billion) stocks with more than 50% returns year to date. These stocks have more upside left for the rest of 2023. These stocks have seen positive earnings estimate revisions in the last 60 days. Each of our picks sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Abercrombie & Fitch Co. (ANF - Free Report) has gained from the continued momentum in the Abercrombie brand and improvement in the Hollister brand. Lower freight costs and robust AUR growth aided ANF’s margins. Consequently, ANF expects fiscal 2023 sales growth of 1-3% from the year-ago period’s reported figure of $3.7 billion. ANF’s store optimization and the Always Forward plan bode well.
Abercrombie & Fitch has an expected revenue and earnings growth rate of 3.4% and more than 100%, respectively, for the current year (ending January 2024). The Zacks Consensus Estimate for current-year earnings has improved 45.6% over the last 60 days. The stock price of ANF has surged 62.2% year to date.
InterDigital Inc. (IDCC - Free Report) is focused on strategic acquisitions in order to drive its product portfolio and boost organic growth. IDCC’s extensive portfolio of wireless technology patents provides a significant competitive advantage. IDCC is poised to gain from future growth opportunities fueled by the 5G rollout, while a strong emphasis on research & development helps it to stay at the forefront of wireless technology innovation.
InterDigital has an expected revenue and earnings growth rate of 17.4% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.1% over the last 60 days. The stock price of IDCC has jumped 95.3% year to date.
Shake Shack Inc. (SHAK - Free Report) has been benefiting from various digital initiatives, strong same-shack sales and unit expansion efforts. SHAK’s digital retention continues to be strong. It has also been making more investments in digitization in an effort to sustain its digital guest enhancement strategies in the near term.
Shake Shack has an expected revenue and earnings growth rate of 21.5% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved more than 100% over the last 60 days. The stock price of SHAK has climbed 92.4% year to date.
Amphastar Pharmaceuticals Inc. (AMPH - Free Report) is a specialty pharmaceutical company. AMPH focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. AMPH’s products include Enoxaparin Sodium Injection, Amphadase, Cortrosyn for Injection, and prefilled disposable emergency syringes for crash cart use.
Amphastar Pharmaceuticals has an expected revenue and earnings growth rate of 17.4% and 30%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.8% over the last 60 days. The stock price of AMPH has soared 118% year to date.
PGT Innovations Inc. pioneered the U.S. impact-resistant window and door industry and today is the nation's leading manufacturer and supplier of residential impact-resistant windows and doors. PGTI is also one of the largest window and door manufacturers in the United States.
PGTI’s total line of custom windows and doors is now available throughout the eastern United States, the Gulf Coast and in a growing international market, which includes the Caribbean, South America, and Australia.
PGT Innovations has an expected revenue and earnings growth rate of 0.5% and 8.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.5% over the last seven days. The stock price of PGTI has advanced 57.8% year to date.